Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
06/2012
06/05/2012CA2286575C Sustained-release compositions and method for preparing same
06/05/2012CA2248667C Hla-a2.1 binding peptides and their uses
06/05/2012CA2233534C Manipulation of non-terminally differentiated cells using the notch pathway
06/05/2012CA2223881C Isolated dna sequence capable of serving as regulatory element in a chimeric gene which can be used for the transformation of plants
06/05/2012CA2187546C Rps2 gene and uses thereof
06/05/2012CA1341630C Transformation vectors allowing expression of foreign polypeptide endotoxins in plants
05/2012
05/31/2012WO2012070977A1 Method for producing web protein, a fused protein, recombinant dna, an expression vector, a host cell and strain-producers
05/31/2012WO2012070974A1 Vaccines with enhanced immunogenicity and methods for the production thereof
05/31/2012WO2012070680A1 Non-fibrillar collagen molded body and method for producing same
05/31/2012WO2012070008A2 Recombinant proteins with a selective inactivation activity on target proteins
05/31/2012WO2012069657A1 Identification of a human gyrovirus and applications.
05/31/2012WO2012069655A2 Improved n-terminal capping modules for designed ankyrin repeat proteins
05/31/2012WO2012069654A1 Designed repeat proteins binding to serum albumin
05/31/2012WO2012069627A1 Covalently linked interleukin-10
05/31/2012WO2012069593A2 Fusion enzymes
05/31/2012WO2012069575A1 Modulation of antigen immunogenicity by deleting epitopes recognized by nkt cells
05/31/2012WO2012069572A1 Modulation of antigen immunogenicity by addition of epitopes recognized by nkt cells
05/31/2012WO2012069568A2 Immunogenic peptides for use in the prevention and/or treatment of infectious diseases, autoimmune diseases, immune responses to allofactors, allergic diseases, tumors, graft rejection and immune responses against viral vectors used for gene therapy or gene vaccination
05/31/2012WO2012069551A1 Dinq-srna type i toxin-antitoxin system for plasmid maintenance
05/31/2012WO2012069474A2 A method for reducing potential virus burden in a sample by cyanate treatment
05/31/2012WO2012069089A1 Human lactoferrin derived peptide for use as an antigen masking agent
05/31/2012WO2012068966A1 Herbicide resistant gene and use thereof
05/31/2012WO2012068637A1 Compositions and methods
05/31/2012WO2012068627A1 Peptides for the specific binding of rna targets
05/31/2012WO2012047968A3 Mutant smoothened and methods of using the same
05/31/2012WO2012044048A3 Conductive bio-nano fusion chain and method for preparing same
05/31/2012WO2012037215A9 Recombinant yeast with improved ethanol tolerance and related methods of use
05/31/2012WO2012036410A3 Modified human tumor necrosis factor receptor-1 polypeptide or fragment thereof, and method for preparing same
05/31/2012WO2012034025A3 Human cytomegalovirus vaccine
05/31/2012WO2012024372A3 Novel bacillus thuringiensis gene with coleopteran activity
05/31/2012WO2012021500A3 Antipathogenic proteins and methods of use
05/31/2012WO2012011752A3 Novel long-acting glucagon conjugate and pharmaceutical composition comprising the same for the prevention and treatment of obesity
05/31/2012WO2012005588A3 Novel biomarkers for detecting neuronal loss
05/31/2012WO2011157447A3 Modified parvovirus having enhanced anti-tumour efficacy
05/31/2012WO2011146933A3 Universal dengue virus sequences and methods of use
05/31/2012WO2011146891A3 High-affinity fully functional soluble single-domain human cd4, antibodies, and related fusion proteins
05/31/2012WO2011142543A3 Atelocollagen separation method, method for preparing modified atelocollagen, and atelocollagen- and collagen-based matrix prepared by the methods
05/31/2012WO2011140132A9 Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of phenylalanyl-alpha-trna synthetases
05/31/2012WO2005018539A8 Influenza hemagglutinin and neuraminidase variants
05/31/2012US20120137385 Transcription factors
05/31/2012US20120137379 Novel aav's and uses thereof
05/31/2012US20120136416 Caged Neuropeptides: modulation and measurement of synapse and signaling activity; and methods for drug evaluation, pharmaceuticals preparation and treatment
05/31/2012US20120136141 Integrin Heterodimer And A Subunit Thereof
05/31/2012US20120136138 Ice-crystal growth inhibiting substance
05/31/2012US20120136073 Amine-Containing Transfection Reagents and methods for making and using same
05/31/2012US20120136057 Hydroxy fatty acid compounds and uses thereof for disease treatment and diagnosis
05/31/2012US20120135931 Method of modifying serine protease inhibitors
05/31/2012US20120135928 Method for purifying recombinant fsh
05/31/2012US20120135922 Modified exendins and exendin agonists
05/31/2012US20120135919 Polymer-drug conjugates
05/31/2012US20120135912 Polypeptide inhibitors of vla4
05/31/2012US20120135516 Artificial antibody polypeptides
05/31/2012US20120135501 Recombinant poxvirus expressing homologous genes inserted
05/31/2012US20120135496 Protein Belonging to the TNF Superfamily Involved in Signal Transduction, Nucleic Acids Encoding Same and Methods of Use Thereof
05/31/2012US20120135495 Neurotoxins with enhanced target specificity
05/31/2012US20120135448 Methods and devices for the fabrication of 3d polymeric fibers
05/31/2012US20120135447 Nucleic acids encoding t2r, a novel family of taste receptors
05/31/2012US20120135442 Protein crystallization using molecularly imprinted polymers
05/31/2012US20120135400 Novel Fluorescent and Colored Proteins, and Polynucleotides that Encode These Proteins
05/31/2012US20120135038 Expression of protective antigens in transgenic chloroplasts and the production of improved vaccines
05/31/2012US20120135037 Flagellin fusion proteins and conjugates comprising pneumococcus antigens and methods of using the same
05/31/2012US20120135034 Non-Integrating Retroviral Vector Vaccines
05/31/2012US20120135031 Method of enhancing an immune response
05/31/2012US20120135030 Method of Producing Protein-Carbohydrate Vaccines Reduced in Free Carbohydrate
05/31/2012US20120135027 Proteins used for the diagnosis of lyme borreliosis
05/31/2012US20120135026 Combination neisserial compositions
05/31/2012US20120135025 Chlamydia antigens and uses thereof
05/31/2012US20120135024 Neisseria meningitidis antigens and compositions
05/31/2012US20120135022 Assembly activating protein (aap) and its use for the manufacture of parvovirus particles essentially consisting of vp3
05/31/2012US20120135019 Fviii peptides for immune tolerance induction and immunodiagnostics
05/31/2012US20120135018 Erg monoclonal antibodies
05/31/2012US20120135017 Stable dry powder composition comprising biologically active microorganisms and/or bioactive materials and methods of making
05/31/2012US20120135011 Method for in vivo expansion of T regulatory cells
05/31/2012US20120134999 PORIN B (PorB) AS A THERAPEUTIC TARGET FOR PREVENTION AND TREATMENT OF INFECTION BY CHLAMYDIA
05/31/2012US20120134997 Polypeptides and polynucleotides, and uses thereof as a drug target for producing drugs and biologics
05/31/2012US20120134991 Compositions and methods for modulating d1-d2 dopamine receptor interaction and function
05/31/2012US20120134977 Prodrugs containing albumin binding probe
05/31/2012US20120134961 Interferon-alpha (IFN-alpha) Fused Protein Having IFN-alpha and Cytoplasmic Transduction Peptide (CTP)
05/31/2012US20120134960 Glycosylated human alpha interferon muteins, method for obtaining them and use
05/31/2012US20120134957 Latent phase viral interleukin-10-(vii-10) and uses thereof
05/31/2012US20120134956 Colloidal metal compositions and methods
05/31/2012US20120134954 Defensin-antigen fusion proteins
05/31/2012US20120134920 Methods and Compositions for Improved F-18 Labeling of Proteins, Peptides and Other Molecules
05/31/2012CA2856565A1 Compositions and methods
05/31/2012CA2820617A1 Immunogenic peptides for use in the prevention and/or treatment of infectious diseases, autoimmune diseases, immune responses to allofactors, allergic diseases, tumors, graft rejection and immune responses against viral vectors used for gene therapy or gene vaccination
05/31/2012CA2819182A1 Modulation of antigen immunogenicity by deleting epitopes recognized by nkt cells
05/31/2012CA2818689A1 Novel signal sequences to improve protein expression and secretion of recombinant enzymes and other proteins
05/31/2012CA2818671A1 Stable preserved compositions of interferon-beta
05/31/2012CA2818581A1 Herbicide resistance gene and use thereof
05/31/2012CA2818536A1 Modulation of antigen immunogenicity by addition of epitopes recognized by nkt cells
05/30/2012EP2457994A1 Method for inducing differentiation of pluripotent stem cells into cardiomyocytes
05/30/2012EP2457930A1 Modified chaperonin 10
05/30/2012EP2457926A1 Novel method for preventing or treating m tuberculosis infection
05/30/2012EP2457924A1 Ion exchange chromatography of proteins and peptides
05/30/2012EP2457920A1 Oligosaccharides comprising an aminooxy group and conjugates thereof
05/30/2012EP2457919A1 Oligosaccharides comprising an aminooxy group and conjugates thereof
05/30/2012EP2457590A2 Protein formulation
05/30/2012EP2457579A1 Covalently linked interleukin -10
05/30/2012EP2457577A1 Diphtheria toxin variant
05/30/2012EP2456878A2 Methods and compositions for improving sugar transport, mixed sugar fermentation, and production of biofuels
1 ... 253 254 255 256 257 258 259 260 261 262 263 264 265 266 267 268 269 270 271 272 273 ... 2916